查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1978579

2026年全球大腸直腸癌篩檢市場報告

Colorectal Cancer Screening Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，大腸直腸癌篩檢市場顯著擴張。預計該市場規模將從2025年的165.6億美元成長到2026年的175.6億美元，複合年成長率（CAGR）為6.1%。過去幾年成長要素包括：結直腸癌發病率上升、國家級篩檢指南的推廣、人們對早期診斷益處的認知不斷提高、糞便檢驗篩檢方法的廣泛應用以及診斷服務可及性的改善。

預計未來幾年大腸癌篩檢市場將維持強勁成長，2030年將達到220.6億美元，複合年成長率（CAGR）為5.9%。預測期內的成長要素包括：年輕族群篩檢率的提高、人工智慧在內視鏡檢查中的應用日益廣泛、遠距遠端醫療篩檢計畫的加強、對個人化癌症風險評估的日益重視以及對預防性醫療保健基礎設施投資的增加。預測期內的主要趨勢包括：非侵入性篩檢檢測的普及率提高、人工智慧輔助大腸鏡檢查系統的使用率增加、家用糞便檢驗試劑盒的需求成長、面向全體人群的篩檢項目擴大以及對早期檢測和預防醫學的日益重視。

預計未來幾年，人口老化將推動大腸癌篩檢市場的成長。人口老化是指由於預期壽命延長和出生率下降，勞動年齡人口中老年人（通常指65歲及以上）比例不斷增加的人口趨勢。隨著預期壽命的延長和出生率的下降，全球人口中老年人的比例持續成長。大腸直腸癌篩檢在滿足日益老化的社會需求方面發揮著至關重要的作用，它能夠實現早期發現和預防措施。這些措施對於控制老年人日益成長的癌症風險和改善其整體健康狀況至關重要。例如，根據美國非營利研究機構人口與社會研究所（PRB）的數據，截至2024年1月，美國65歲及以上人口數量預計將從2022年的5,800萬增加到2050年的8,200萬，增幅達47%。此外，老年人口佔總人口的比例預計將從17%上升到23%。因此，人口老化是大腸直腸癌篩檢市場的重要驅動力。

大腸直腸癌篩檢市場的主要企業正致力於開發創新解決方案，例如非侵入性多標靶糞便核糖核酸 (RNA) 結直腸癌篩檢檢測，以提供便捷有效的早期檢測方法，從而改善患者預後並促進更廣泛的篩檢參與。非侵入性多靶點糞便 RNA 結直腸癌篩檢檢測透過評估糞便檢體中的 RNA 標記來識別大腸直腸癌或癌前病變，提供了一種非手術的早期檢測方法。例如，2024 年 5 月，美國生命科學公司 Geneoscopy Inc. 宣布其 ColoSense 檢測已獲得美國食品藥物管理局(FDA) 的核准。糞便檢驗，在檢測結直腸癌方面具有 93% 的靈敏度，在檢測進行性腺瘤方面具有 45% 的靈敏度。其意義在於其高準確性，尤其是在年輕人群中，並且它有望透過提供比傳統方法更微創的替代方案來提高篩檢率。

目錄

第1章：執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球大腸直腸癌篩檢市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 人工智慧（AI）和自主人工智慧
    • 生物技術、基因組學和精準醫療
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施、互聯生態系統
  • 主要趨勢
    • 非侵入性篩檢測試的廣泛應用
    • 擴大人工智慧輔助大腸鏡檢查系統的應用
    • 家用糞便檢驗試劑盒的需求正在增加。
    • 擴大篩檢項目範圍，涵蓋全體人口
    • 加強對早期檢測和預防醫學的重視

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 臨床檢查室
  • 診斷影像中心
  • 預防醫學中心
  • 公共衛生篩檢計劃

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球大腸直腸癌篩檢市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球大腸直腸癌篩檢市場規模、對比及成長率分析
  • 全球大腸直腸癌篩檢市場表現：規模與成長，2020-2025年
  • 全球大腸癌篩檢市場預測：規模與成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 按類型
  • 糞便檢驗、糞便免疫化學檢查(FIT)、大便潛血試驗(FOBT)、糞便去氧核糖核酸(DNA) 檢查、大腸鏡檢查及其他類型檢查。
  • 按年齡層
  • 50歲以下、50-64歲、65歲以上
  • 最終用戶
  • 醫院和診所、臨床檢查室、診斷影像中心和其他終端用戶
  • 按類型細分：糞便檢驗
  • 糞便檢驗
  • 亞型分類：糞便免疫化學檢查（FIT）
  • 高靈敏度 FIT，低靈敏度 FIT
  • 按類型細分：大便潛血試驗（FOBT）
  • 癒創木脂法糞便隱血試驗、免疫化學法糞便隱血試驗
  • 按類型細分：糞便去氧核糖核酸(DNA) 檢測
  • 多標靶糞便DNA檢測，單一標靶糞便DNA檢測
  • 按類型細分：大腸鏡檢查
  • 診斷性大腸鏡檢查、治療性大腸鏡檢查
  • 按類型細分：其他類型
  • 虛擬大腸鏡檢查、乙狀結腸鏡檢查、膠囊內視鏡檢查

第10章 市場與產業指標：依國家分類

第11章 區域與國別分析

  • 全球大腸癌篩檢市場：按地區分類，實際結果和預測，2020-2025年、2025-2030年、2035年
  • 全球大腸癌篩檢市場：按國家/地區分類，實際數據和預測數據，2020-2025 年、2025-2030 年、2035 年

第12章 亞太市場

第13章：中國市場

第14章：印度市場

第15章：日本市場

第16章：澳洲市場

第17章：印尼市場

第18章：韓國市場

第19章 台灣市場

第20章：東南亞市場

第21章 西歐市場

第22章英國市場

第23章：德國市場

第24章：法國市場

第25章：義大利市場

第26章：西班牙市場

第27章 東歐市場

第28章：俄羅斯市場

第29章 北美市場

第30章：美國市場

第31章：加拿大市場

第32章：南美洲市場

第33章：巴西市場

第34章 中東市場

第35章：非洲市場

第36章 市場監理與投資環境

第37章：競爭格局與公司概況

  • 大腸直腸癌篩檢市場：競爭格局和市場佔有率（2024 年）
  • 大腸直腸癌篩檢市場：公司估值矩陣
  • 大腸直腸癌篩檢市場：公司概況
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Medtronic plc
    • Siemens Healthineers

第38章 其他大型企業和創新企業

  • FUJIFILM Holdings Corporation, GE HealthCare, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, QIAGEN NV, Exact Sciences Corporation, Guardant Health Inc., Eiken Chemical Co. Ltd., HemoCue AB, Clinical Genomics Inc., Polymedco LLC

第39章 全球市場競爭基準分析與儀錶板

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

  • 2030年大腸癌篩檢市場：提供新機會的國家
  • 2030年大腸直腸癌篩檢市場：蘊藏新機會的細分市場
  • 2030年大腸癌篩檢市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第42章附錄

簡介目錄
Product Code: IT3MCCSA04_G26Q1

Colorectal cancer screening refers to testing procedures aimed at detecting early signs of colorectal cancer before symptoms manifest. Early detection through screening can identify precancerous polyps or cancer at a more treatable stage, significantly enhancing patient outcomes. Screening is recommended for adults starting at age 45, or earlier for those at higher risk.

The primary types of colorectal cancer screening include stool-based tests, fecal immunochemical tests (FIT), fecal occult blood tests (FOBT), stool deoxyribonucleic acid (DNA) tests, and colonoscopy, among others. Stool-based colorectal cancer screening involves analyzing a stool sample for indicators of cancer-related substances or abnormalities, such as blood or DNA mutations, to identify potential colorectal cancer. These screenings are categorized by age groups, including individuals under 50, those aged 50-64, and those over 65. The end users of these tests encompass hospitals and clinics, clinical laboratories, diagnostic imaging centers, and other healthcare providers.

Tariffs are impacting the colorectal cancer screening market by increasing costs of imported diagnostic devices, endoscopy equipment, imaging components, reagents, and test kits used in screening procedures. Hospitals, diagnostic laboratories, and imaging centers in North America and Europe are most affected due to reliance on imported medical devices, while Asia-Pacific faces higher costs for equipment manufacturing and distribution. These tariffs are increasing procedural costs and delaying equipment upgrades. However, they are also encouraging domestic production of diagnostic kits, local manufacturing of screening devices, and regional supply chain strengthening.

The colorectal cancer screening market research report is one of a series of new reports from The Business Research Company that provides colorectal cancer screening market statistics, including colorectal cancer screening industry global market size, regional shares, competitors with a colorectal cancer screening market share, detailed colorectal cancer screening market segments, market trends and opportunities, and any further data you may need to thrive in the colorectal cancer screening industry. This colorectal cancer screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The colorectal cancer screening market size has grown strongly in recent years. It will grow from $16.56 billion in 2025 to $17.56 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to rising prevalence of colorectal cancer, expansion of national screening guidelines, increasing awareness of early diagnosis benefits, adoption of fecal-based screening methods, improved access to diagnostic services.

The colorectal cancer screening market size is expected to see strong growth in the next few years. It will grow to $22.06 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing screening uptake among younger populations, growing integration of AI in endoscopy procedures, expansion of telehealth-supported screening programs, rising focus on personalized cancer risk assessment, increasing investments in preventive healthcare infrastructure. Major trends in the forecast period include increasing adoption of non-invasive screening tests, rising use of AI-assisted colonoscopy systems, growing demand for home-based stool testing kits, expansion of population-wide screening programs, enhanced focus on early detection and preventive care.

The increasing aging population is projected to drive the growth of the colorectal cancer screening market in the coming years. An aging population refers to a demographic trend characterized by a rising proportion of elderly individuals (typically those aged 65 and older) relative to the working-age population, often resulting from longer life expectancies and declining birth rates. As life expectancies increase and birth rates decline, the share of older adults in the global population continues to grow. Colorectal cancer screening plays a crucial role in addressing the needs of this expanding aging population by enabling early detection and preventive measures, which are essential for managing the heightened cancer risk among older adults and improving their overall health outcomes. For example, in January 2024, data from the Population Reference Bureau (PRB), a U.S.-based nonprofit research organization, projected that the number of Americans aged 65 and older would rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, their share of the total population is expected to grow from 17% to 23%. Thus, the increasing aging population is a significant driver of the colorectal cancer screening market.

Key players in the colorectal cancer screening market are focusing on developing innovative solutions, such as non-invasive multi-target stool ribonucleic acid (RNA) colorectal cancer screening tests, to provide accessible and effective early detection methods, thereby improving patient outcomes and promoting wider screening participation. Non-invasive multi-target stool RNA colorectal cancer screening tests evaluate RNA markers from stool samples to identify the presence of colorectal cancer or precancerous lesions, offering a non-surgical approach for early detection. For instance, in May 2024, Geneoscopy Inc., a U.S.-based life sciences company, announced that it received U.S. Food and Drug Administration (FDA) approval for ColoSense. This test utilizes RNA biomarkers for a non-invasive, stool-based screening method that demonstrated 93% sensitivity in detecting colorectal cancer and 45% sensitivity for advanced adenomas. Its significance lies in its high accuracy, particularly among younger populations, and its potential to enhance screening rates by providing a less invasive alternative to traditional methods.

In November 2023, Geneoscopy Inc. partnered with Laboratory Corporation (LabCorp), a U.S.-based life science and healthcare company, to broaden access to Geneoscopy's non-invasive multi-target stool RNA colorectal cancer screening test. This collaboration aims to improve early and sensitive detection of colorectal cancer and precancerous lesions, address health disparities, and increase screening rates by leveraging LabCorp's extensive network of healthcare providers and patients. LabCorp is known for offering colon cancer screening and diagnostic tests.

Major companies operating in the colorectal cancer screening market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers, FUJIFILM Holdings Corporation, GE HealthCare, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., Eiken Chemical Co. Ltd., HemoCue AB, Clinical Genomics Inc., Polymedco LLC, Hemosure Inc., Geneoscopy Inc., Novigenix SA

North America was the largest region in the colorectal cancer screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the colorectal cancer screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The colorectal cancer screening market includes revenues earned by entities by providing services such as genetic and molecular testing, patient education and awareness programs, and screening result analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Colorectal Cancer Screening Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses colorectal cancer screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for colorectal cancer screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The colorectal cancer screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Stool-Based; Fecal Immunochemical Test (FIT); Fecal Occult Blood Test (FOBT); Stool Deoxyribonucleic Acid (DNA) Test; Colonoscopy; Other Types
  • 2) By Age Group: Below 50 Years; 50-64 Years; Above 65 Years
  • 3) By End User: Hospitals And Clinics; Clinical Laboratories; Diagnostic Imaging Centers; Other End-Users
  • Subsegments:
  • 1) By Stool-Based: Stool-Based Tests
  • 2) By Fecal Immunochemical Test (FIT): High-Sensitivity FIT; Low-Sensitivity FIT
  • 3) By Fecal Occult Blood Test (FOBT): Guaiac FOBT; Immunochemical FOBT
  • 4) By Stool Deoxyribonucleic Acid (DNA) Test: Multi-Target Stool DNA Test; Single-Target Stool DNA Test
  • 5) By Colonoscopy: Diagnostic Colonoscopy; Therapeutic Colonoscopy
  • 6) By Other Types: Virtual Colonoscopy; Flexible Sigmoidoscopy; Capsule Endoscopy
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Medtronic plc; Siemens Healthineers; FUJIFILM Holdings Corporation; GE HealthCare; Boston Scientific Corporation; Olympus Corporation; Hologic Inc.; bioMerieux SA; QuidelOrtho Corporation; Sysmex Corporation; QIAGEN N.V.; Exact Sciences Corporation; Guardant Health Inc.; Eiken Chemical Co. Ltd.; HemoCue AB; Clinical Genomics Inc.; Polymedco LLC; Hemosure Inc.; Geneoscopy Inc.; Novigenix SA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Colorectal Cancer Screening Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Colorectal Cancer Screening Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Colorectal Cancer Screening Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Colorectal Cancer Screening Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Non-Invasive Screening Tests
    • 4.2.2 Rising Use Of AI-Assisted Colonoscopy Systems
    • 4.2.3 Growing Demand For Home-Based Stool Testing Kits
    • 4.2.4 Expansion Of Population-Wide Screening Programs
    • 4.2.5 Enhanced Focus On Early Detection And Preventive Care

5. Colorectal Cancer Screening Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Clinical Laboratories
  • 5.3 Diagnostic Imaging Centers
  • 5.4 Preventive Healthcare Centers
  • 5.5 Public Health Screening Programs

6. Colorectal Cancer Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Colorectal Cancer Screening Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Colorectal Cancer Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Colorectal Cancer Screening Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Colorectal Cancer Screening Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Colorectal Cancer Screening Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Colorectal Cancer Screening Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Colorectal Cancer Screening Market Segmentation

  • 9.1. Global Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Stool-Based, Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT), Stool Deoxyribonucleic Acid (DNA) Test, Colonoscopy, Other Types
  • 9.2. Global Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Below 50 Years, 50-64 Years, Above 65 Years
  • 9.3. Global Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Clinical Laboratories, Diagnostic Imaging Centers, Other End-Users
  • 9.4. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Stool-Based, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Stool-Based Tests
  • 9.5. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Fecal Immunochemical Test (FIT), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • High-Sensitivity FIT, Low-Sensitivity FIT
  • 9.6. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Fecal Occult Blood Test (FOBT), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Guaiac FOBT, Immunochemical FOBT
  • 9.7. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Stool Deoxyribonucleic Acid (DNA) Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Multi-Target Stool DNA Test, Single-Target Stool DNA Test
  • 9.8. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Colonoscopy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Colonoscopy, Therapeutic Colonoscopy
  • 9.9. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Virtual Colonoscopy, Flexible Sigmoidoscopy, Capsule Endoscopy

10. Colorectal Cancer Screening Market, Industry Metrics By Country

  • 10.1. Global Colorectal Cancer Screening Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • 10.2. Global Colorectal Cancer Screening Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. Colorectal Cancer Screening Market Regional And Country Analysis

  • 11.1. Global Colorectal Cancer Screening Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 11.2. Global Colorectal Cancer Screening Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific Colorectal Cancer Screening Market

  • 12.1. Asia-Pacific Colorectal Cancer Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. Asia-Pacific Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China Colorectal Cancer Screening Market

  • 13.1. China Colorectal Cancer Screening Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 13.2. China Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India Colorectal Cancer Screening Market

  • 14.1. India Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan Colorectal Cancer Screening Market

  • 15.1. Japan Colorectal Cancer Screening Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 15.2. Japan Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia Colorectal Cancer Screening Market

  • 16.1. Australia Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia Colorectal Cancer Screening Market

  • 17.1. Indonesia Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea Colorectal Cancer Screening Market

  • 18.1. South Korea Colorectal Cancer Screening Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. South Korea Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan Colorectal Cancer Screening Market

  • 19.1. Taiwan Colorectal Cancer Screening Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. Taiwan Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia Colorectal Cancer Screening Market

  • 20.1. South East Asia Colorectal Cancer Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. South East Asia Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe Colorectal Cancer Screening Market

  • 21.1. Western Europe Colorectal Cancer Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 21.2. Western Europe Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK Colorectal Cancer Screening Market

  • 22.1. UK Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany Colorectal Cancer Screening Market

  • 23.1. Germany Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France Colorectal Cancer Screening Market

  • 24.1. France Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy Colorectal Cancer Screening Market

  • 25.1. Italy Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain Colorectal Cancer Screening Market

  • 26.1. Spain Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe Colorectal Cancer Screening Market

  • 27.1. Eastern Europe Colorectal Cancer Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 27.2. Eastern Europe Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia Colorectal Cancer Screening Market

  • 28.1. Russia Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America Colorectal Cancer Screening Market

  • 29.1. North America Colorectal Cancer Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. North America Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA Colorectal Cancer Screening Market

  • 30.1. USA Colorectal Cancer Screening Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. USA Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada Colorectal Cancer Screening Market

  • 31.1. Canada Colorectal Cancer Screening Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. Canada Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America Colorectal Cancer Screening Market

  • 32.1. South America Colorectal Cancer Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 32.2. South America Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil Colorectal Cancer Screening Market

  • 33.1. Brazil Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East Colorectal Cancer Screening Market

  • 34.1. Middle East Colorectal Cancer Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Middle East Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa Colorectal Cancer Screening Market

  • 35.1. Africa Colorectal Cancer Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 35.2. Africa Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Colorectal Cancer Screening Market Regulatory and Investment Landscape

37. Colorectal Cancer Screening Market Competitive Landscape And Company Profiles

  • 37.1. Colorectal Cancer Screening Market Competitive Landscape And Market Share 2024
    • 37.1.1. Top 10 Companies (Ranked by revenue/share)
  • 37.2. Colorectal Cancer Screening Market - Company Scoring Matrix
    • 37.2.1. Market Revenues
    • 37.2.2. Product Innovation Score
    • 37.2.3. Brand Recognition
  • 37.3. Colorectal Cancer Screening Market Company Profiles
    • 37.3.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

38. Colorectal Cancer Screening Market Other Major And Innovative Companies

  • FUJIFILM Holdings Corporation, GE HealthCare, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., Eiken Chemical Co. Ltd., HemoCue AB, Clinical Genomics Inc., Polymedco LLC

39. Global Colorectal Cancer Screening Market Competitive Benchmarking And Dashboard

40. Key Mergers And Acquisitions In The Colorectal Cancer Screening Market

41. Colorectal Cancer Screening Market High Potential Countries, Segments and Strategies

  • 41.1. Colorectal Cancer Screening Market In 2030 - Countries Offering Most New Opportunities
  • 41.2. Colorectal Cancer Screening Market In 2030 - Segments Offering Most New Opportunities
  • 41.3. Colorectal Cancer Screening Market In 2030 - Growth Strategies
    • 41.3.1. Market Trend Based Strategies
    • 41.3.2. Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer